Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR — Stella

Recruiting

Back to Neurodegenerative Diseases trials

Trial locations(1 site)

United Kingdom

University of Exeter, Exeter

Key details

Sponsor

University of Exeter

Enrollment target

~30 participants

Started

February 2022

Primary completion

August 2026

Age range

50 Years – 85 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov